COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 54: Articles 531-540  | Next

Beyond the freedom to refuse patient: a retrospective comparative study of emergency transportation during the COVID-19 pandemic in Japan
Hirata, K., Chiba, T., Takaku, R., Meilai, C., Ikeda, S., Shiga, T.
10.1101/2025.08.19.25334036 — Posted: 2025-08-24
Integrative Modeling of SARS-CoV-2 Infection Dynamics to Inform COVID-19 Vaccination Strategies
Waema, R., Kaumbutha, C. M., Orwa, T.
10.1101/2025.08.19.25333964 — Posted: 2025-08-24
Factors associated with severe COVID-19 outcomes among adults with at least a primary vaccination schedule: a retrospective cohort study from Alberta, Canada
Aponte-Hao, S., Luu, H., Martins, K. J. B., Randall, J. R., Saxinger, L., Rennert-May, E., Leal, J., Williamson, T., Wilson, A., Blake, M., Lu, T., Iqbal, S. M., Mansi, J. A., Araujo, A. B., Martin, D., Klarenbach, S. W.
10.1101/2025.08.19.25334000 — Posted: 2025-08-24
Longitudinal and socio-demographic trends in Long COVID and associated activity limitations: Results from the New York City Community Health Survey 2021 - 2023
Packard, S. E., Lans, A., Shi, Y., Chamany, S.
10.1101/2025.08.20.25334102 — Posted: 2025-08-24
Pediatric Long COVID Is Characterized by Myeloid CCR6 Suppression and Immune Dysregulation
Izquierdo-Pujol, J., Pedreno-Lopez, N., Pidkova, T., Nevot, M., Urrea, V., Laguia, F., Munoz-Lopez, F., Dalmau, J., Gonzalez-Aumatell, A., Carreras-Abad, C., Mendez, M., Rodrigo, C., Massanella, M., Blanco, J., Carrillo, J., Trinite, B., Martinez-Picado, J., Moron-Lopez, S.
10.1101/2025.08.22.671713 — Posted: 2025-08-22
Wastewater-based Surveillance as a tool for monitoring and estimating COVID-19 incidence and trends: Insights from Germany, 2022-2024
Abunijela, S., Pütz, P., Greiner, T., Lehfeld, A.-S., Schattschneider, A., Buchholz, U., Schumacher, J.
10.1101/2025.08.19.25333953 — Posted: 2025-08-21
Quantifying contributing factors for hospitalization inequalities: influenza and COVID-19, England, 2023 to 2024
Scott, M., Browning, L., Roberts, T., Richardson, Z. A.
10.1101/2025.08.14.25333430 — Posted: 2025-08-21
The experience of conducting non-pandemic research during the COVID-19 pandemic: a case study
June, M. J., Otiti, M. I., Mbanda, N. O., Miruye, P. O., Allen, S. J., OMathuna, D.
10.1101/2025.08.15.25333770 — Posted: 2025-08-20
Orthorhombic coronavirus main protease crystals provide a higher success rate in fragment screening
Barthel, T., Wollenhaupt, J., Benz, L. S., Reinke, P. Y. A., Zhang, L., Oelker, M., Lennartz, F., Taberman, H., Mueller, U., Meents, A., Hilgenfeld, R., Weiss, M. S.
10.1101/2025.08.20.671191 — Posted: 2025-08-20
Counterfactual evaluation of elementary and secondary school policies in the COVID-19 pandemic
Canfora, B., Escosio, R. A., Boldea, O., Nunes, A., Rozhnova, G.
10.1101/2025.08.17.25333861 — Posted: 2025-08-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).